Evidence map›Paper›PMID 42193387›Full record

ArticleBiomedicines2026

Integrative Multi-Omics and Pan-Cancer Analyses Identify CCL20 as a Prognostic Biomarker with Therapeutic Relevance in Esophageal Cancer.

Shixiang Guo, Xiaoyu Chen, Mingfeng Wei, Fuzhi Yang, Shuai Jiang, Liting Zhao, Lefei Hu, Zheng Li, Xiaoyong Shen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shixiang GuoShanghai Key Laboratory of Clinical Geriatric Medicine, Affiliated Huadong Hospital, Fudan University, Shanghai 200040, China.
Xiaoyu ChenDepartment of Thoracic Surgery, Affiliated Huadong Hospital, Fudan University, Shanghai 200040, China.
Mingfeng WeiDepartment of Thoracic Surgery, Affiliated Huadong Hospital, Fudan University, Shanghai 200040, China.
Fuzhi YangShanghai Key Laboratory of Clinical Geriatric Medicine, Affiliated Huadong Hospital, Fudan University, Shanghai 200040, China.
Shuai JiangDepartment of Thoracic Surgery, Affiliated Huadong Hospital, Fudan University, Shanghai 200040, China.
Liting ZhaoDepartment of General Surgery, Affiliated Huadong Hospital, Fudan University, Shanghai 200040, China.
Lefei HuShanghai Key Laboratory of Clinical Geriatric Medicine, Affiliated Huadong Hospital, Fudan University, Shanghai 200040, China.
Zheng LiDepartment of Thoracic Surgery, Affiliated Huadong Hospital, Fudan University, Shanghai 200040, China.
Xiaoyong ShenDepartment of Thoracic Surgery, Affiliated Huadong Hospital, Fudan University, Shanghai 200040, China.

Funding

the National Natural Science Foundation of China No. 82372611
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CCL20esophageal cancerimmune microenvironmentpan-cancer analysissingle-cell RNA sequencingtherapeutic target

Identifiers

PMID42193387
PMCPMC13204176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.